• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetic variability in IGF-1 and IGFBP-3 and body size in early life.IGF-1 和 IGFBP-3 的遗传变异性与生命早期的体型。
BMC Public Health. 2012 Aug 15;12:659. doi: 10.1186/1471-2458-12-659.
2
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白-1(IGFBP-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)基因多态性可预测循环中IGF水平,但不能预测乳腺癌风险:来自乳腺癌和前列腺癌队列联盟(BPC3)的研究结果。
PLoS One. 2008 Jul 2;3(7):e2578. doi: 10.1371/journal.pone.0002578.
3
Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin-insulin-like growth factor system.从 5 岁到 60 岁的体脂肪轨迹和胰岛素-胰岛素样生长因子系统的血浆生物标志物浓度。
Am J Clin Nutr. 2018 Aug 1;108(2):388-397. doi: 10.1093/ajcn/nqy103.
4
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.老年人血清胰岛素样生长因子(IGF)-I和IGF结合蛋白-1:与心血管危险因素、身体组成、出生时大小及儿童期生长的关系
J Clin Endocrinol Metab. 2003 Mar;88(3):1059-65. doi: 10.1210/jc.2002-021380.
5
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.IGFI、IGFII、IGFBP-1 和 IGFBP-3 内常见的遗传变异与子宫内膜癌风险。
Gynecol Oncol. 2011 Feb;120(2):174-8. doi: 10.1016/j.ygyno.2010.10.012.
6
Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.多族裔人群中循环胰岛素样生长因子(IGF)-I、IGF结合蛋白(BP)-1和IGFBP-3水平的遗传决定因素。
J Clin Endocrinol Metab. 2007 Sep;92(9):3660-6. doi: 10.1210/jc.2007-0790. Epub 2007 Jun 12.
7
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.IGF1、IGFBP1 和 IGFBP3 中的常见遗传变异与卵巢癌风险。
Carcinogenesis. 2009 Dec;30(12):2042-6. doi: 10.1093/carcin/bgp257.
8
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.IGF-I和IGFBP-3的基因变异及循环水平与增殖性良性乳腺疾病风险的关系
Int J Cancer. 2010 Jan 1;126(1):180-90. doi: 10.1002/ijc.24674.
9
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.胰岛素样生长因子-1、胰岛素样生长因子结合蛋白-3、生长激素与护士健康研究中的乳腺密度。
Breast Cancer Res Treat. 2012 Dec;136(3):805-12. doi: 10.1007/s10549-012-2303-2. Epub 2012 Oct 21.
10
Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子-2(IGF2)、胰岛素样生长因子-1受体(IGF-1R)、胰岛素样生长因子-2受体(IGF-2R)、胰岛素样生长因子结合蛋白-3(IGFBP-3)、胰岛素基因多态性与女童中枢性性早熟之间的关联。
BMC Endocr Disord. 2018 Sep 19;18(1):66. doi: 10.1186/s12902-018-0271-1.

引用本文的文献

1
A Possible Link of Genetic Variations in ER/IGF1R Pathway and Risk of Melanoma.可能与 ER/IGF1R 通路中遗传变异相关的黑色素瘤风险。
Int J Mol Sci. 2020 Mar 5;21(5):1776. doi: 10.3390/ijms21051776.
2
Association between the insulin-like growth factor 1 gene rs2195239 and rs2162679 polymorphisms and cancer risk: a meta-analysis.胰岛素样生长因子 1 基因 rs2195239 和 rs2162679 多态性与癌症风险的关联:荟萃分析。
BMC Med Genet. 2019 Jan 17;20(1):17. doi: 10.1186/s12881-019-0749-3.
3
The association between IGF1 gene rs1520220 polymorphism and cancer susceptibility: a meta-analysis based on 12,884 cases and 58,304 controls.IGF1 基因 rs1520220 多态性与癌症易感性的关联:基于 12884 例病例和 58304 例对照的荟萃分析。
Environ Health Prev Med. 2018 Aug 16;23(1):38. doi: 10.1186/s12199-018-0727-y.
4
Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysis.胰岛素样生长因子结合蛋白-3基因多态性-202A/C与前列腺癌风险的关联:一项荟萃分析。
Onco Targets Ther. 2016 Sep 6;9:5451-9. doi: 10.2147/OTT.S107595. eCollection 2016.
5
The interaction between early-life body size and physical activity on risk of breast cancer.早期身体大小与体育活动对乳腺癌风险的相互作用。
Int J Cancer. 2015 Aug 1;137(3):571-81. doi: 10.1002/ijc.29272. Epub 2014 Nov 10.

本文引用的文献

1
Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3.婴儿期的体型与成年期的胰岛素样生长因子 1 和胰岛素样生长因子结合蛋白 3 水平。
Am J Epidemiol. 2011 Sep 15;174(6):642-51. doi: 10.1093/aje/kwr123. Epub 2011 Aug 9.
2
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.IGFI、IGFII、IGFBP-1 和 IGFBP-3 内常见的遗传变异与子宫内膜癌风险。
Gynecol Oncol. 2011 Feb;120(2):174-8. doi: 10.1016/j.ygyno.2010.10.012.
3
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.胰岛素样生长因子 1(IGF1)、胰岛素样生长因子结合蛋白 3(IGFBP3)与乳腺癌风险:17 项前瞻性研究的汇总个体数据分析。
Lancet Oncol. 2010 Jun;11(6):530-42. doi: 10.1016/S1470-2045(10)70095-4. Epub 2010 May 14.
4
Family-based association study of IGF1 microsatellites and height, weight, and body mass index.基于家系的 IGF1 微卫星与身高、体重和体重指数的关联研究。
J Hum Genet. 2010 Apr;55(4):255-8. doi: 10.1038/jhg.2010.17. Epub 2010 Mar 19.
5
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.IGF1、IGFBP1 和 IGFBP3 中的常见遗传变异与卵巢癌风险。
Carcinogenesis. 2009 Dec;30(12):2042-6. doi: 10.1093/carcin/bgp257.
6
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.IGF-I和IGFBP-3的基因变异及循环水平与增殖性良性乳腺疾病风险的关系
Int J Cancer. 2010 Jan 1;126(1):180-90. doi: 10.1002/ijc.24674.
7
IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.非裔美国女性和白种女性中胰岛素样生长因子-I(IGF-I)及胰岛素样生长因子结合蛋白-3(IGFBP-3)基因多态性与循环水平的关系
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):954-66. doi: 10.1158/1055-9965.EPI-08-0856. Epub 2009 Feb 24.
8
Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.胰岛素样生长因子-1和白细胞介素-6相关基因变异与多发性骨髓瘤风险
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):282-8. doi: 10.1158/1055-9965.EPI-08-0778.
9
Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.早年体型与上皮性卵巢癌风险:护士健康研究的结果
Br J Cancer. 2008 Dec 2;99(11):1916-22. doi: 10.1038/sj.bjc.6604742. Epub 2008 Oct 28.
10
Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women.
Breast Cancer Res Treat. 2009 Jul;116(2):413-23. doi: 10.1007/s10549-008-0146-7. Epub 2008 Sep 11.

IGF-1 和 IGFBP-3 的遗传变异性与生命早期的体型。

Genetic variability in IGF-1 and IGFBP-3 and body size in early life.

机构信息

Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

出版信息

BMC Public Health. 2012 Aug 15;12:659. doi: 10.1186/1471-2458-12-659.

DOI:10.1186/1471-2458-12-659
PMID:22894543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3508796/
Abstract

BACKGROUND

Early life body size and circulating levels of IGF-1 and IGFBP-3 have been linked to increased risks of breast and other cancers, but it is unclear whether these exposures act through a common mechanism. Previous studies have examined the role of IGF-1 and IGFBP-3 genetic variation in relation to adult height and body size, but few studies have examined associations with birthweight and childhood size.

METHODS

We examined whether htSNPs in IGF-1 and the IGFBP-1/IGFBP-3 gene region are associated with the self-reported outcomes of birthweight, body fatness at ages 5 and 10, and body mass index (BMI) at age 18 among healthy women from the Nurses' Health Study (NHS) and NHSII. We used ordinal logistic regression to model odds ratios (ORs) and 95% confidence intervals (CI) of a one category increase for birthweight and somatotypes at ages 5 and 10. We used linear regression to model associations with BMI at age 18.

RESULTS

Among 4567 healthy women in NHS and NHSII, we observed no association between common IGF-1 or IGFBP-1/IGFBP-3 SNPs and birthweight, body fatness at ages 5 and 10, or BMI at age 18.

CONCLUSIONS

Common IGF-1 and IGFBP-1/IGFBP-3 SNPs are not associated with body size in early life.

摘要

背景

婴儿期的身体大小和循环中的 IGF-1 和 IGFBP-3 水平与增加乳腺癌和其他癌症的风险有关,但尚不清楚这些暴露是否通过共同的机制起作用。先前的研究已经研究了 IGF-1 和 IGFBP-1/IGFBP-3 基因区域中的遗传变异与成人身高和体型的关系,但很少有研究检查与出生体重和儿童期体型的关联。

方法

我们研究了 IGF-1 中的 htSNPs 以及 IGFBP-1/IGFBP-3 基因区域中的 SNPs 是否与健康女性的出生体重、5 岁和 10 岁时的体脂肪率以及 18 岁时的体重指数 (BMI) 有关。我们使用有序逻辑回归模型来对出生体重和 5 岁和 10 岁时的体型进行单一类别增加的比值比 (OR) 和 95%置信区间 (CI)。我们使用线性回归模型来关联 BMI 与 18 岁时的 BMI。

结果

在 NHS 和 NHSII 中的 4567 名健康女性中,我们没有观察到常见的 IGF-1 或 IGFBP-1/IGFBP-3 SNP 与出生体重、5 岁和 10 岁时的体脂肪率或 18 岁时的 BMI 之间存在关联。

结论

常见的 IGF-1 和 IGFBP-1/IGFBP-3 SNP 与婴儿期的体型大小无关。